These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5802885)

  • 21. Current concepts of histocompatibility.
    Mittal KK
    Can J Med Technol; 1972 Oct; 34(5):179-84. PubMed ID: 5084358
    [No Abstract]   [Full Text] [Related]  

  • 22. Histocompatibility antigens.
    Davies DA
    Proc Can Cancer Conf; 1969; 8():381-9. PubMed ID: 5792938
    [No Abstract]   [Full Text] [Related]  

  • 23. Insights from the immunopathology of transplantation.
    Platt JL
    Springer Semin Immunopathol; 2003 Sep; 25(2):91-4. PubMed ID: 12955461
    [No Abstract]   [Full Text] [Related]  

  • 24. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tissue typing and donor-recipient selection in dogs for experimental organ transplants].
    Schimmack L; Kaden J; Groth J; Engelmann C
    Z Exp Chir; 1980; 13(4):213-20. PubMed ID: 7415346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The major histocompatibility complex in man: a molecular approach].
    Giphart MJ
    Ned Tijdschr Geneeskd; 1982 Jan; 126(4):154-61. PubMed ID: 6173776
    [No Abstract]   [Full Text] [Related]  

  • 28. The egg and immunology.
    Kirby DR
    Proc R Soc Med; 1970 Jan; 63(1):59-61. PubMed ID: 5417781
    [No Abstract]   [Full Text] [Related]  

  • 29. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens].
    Nesterenko VG; Gruner ShG
    Biull Eksp Biol Med; 1980 Jun; 89(6):708-10. PubMed ID: 6967339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems of histocompatibility in transplantation].
    Matej H
    Postepy Hig Med Dosw; 1970; 24(5):639-711. PubMed ID: 5496180
    [No Abstract]   [Full Text] [Related]  

  • 32. Life span of mice in long-term parabiosis.
    Mansur GP; Sjaarda JR; Walford RL
    Arch Pathol; 1968 Apr; 85(4):410-5. PubMed ID: 5651238
    [No Abstract]   [Full Text] [Related]  

  • 33. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Host choice for organ transplantations by means of a desk computer].
    Mayr WR; Mickerts D
    Wien Med Wochenschr; 1970 May; 120(18):334-7. PubMed ID: 5490868
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective inability of LPS-activated B lymphocytes to produce antibodies against autologous and allogeneic MHC class I antigens.
    Jiang Y; Möller G
    Cell Immunol; 1994 May; 155(2):394-401. PubMed ID: 8181073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed lymphocyte cultures and histocompatibility antigens in mice.
    Rychlíková M; Iványi P
    Folia Biol (Praha); 1969; 15(2):126-35. PubMed ID: 5795049
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical implications of transplantation immunology.
    Lawrence HS
    N Y State J Med; 1968 Oct; 68(19):2542-6. PubMed ID: 5245367
    [No Abstract]   [Full Text] [Related]  

  • 38. The genetic control of the histocompatibilty antigens.
    Barnes AD; Cooper B
    Br J Surg; 1968 Nov; 55(11):873. PubMed ID: 5687037
    [No Abstract]   [Full Text] [Related]  

  • 39. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 50-year retrospective: cell-mediated immunity and the major histocompatibility complex.
    Bach FH
    Transplant Proc; 1999; 31(1-2):16-7. PubMed ID: 10082996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.